|
1
|
Shike M, Winawer SJ, Greenwald PH, Bloch
A, Hill MJ and Swaroop SV: Primary prevention of colorectal cancer.
The WHO Collaborating Center for the Prevention of Colorectal
Cancer. Bull World Health Organ. 68:377–385. 1990.PubMed/NCBI
|
|
2
|
Winawer SJ, Fletcher RH, Miller L, et al:
Colorectal cancer screening: clinical guidelines and rationale.
Gastroenterology. 112:594–642. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007. View Article : Google Scholar
|
|
5
|
Zhang Y, Zhang X, Wang X, Gan L, Yu G,
Chen Y, Liu K, Li P, Pan J, Wang J and Qin S: Inhibition of LDH-A
by lentivirus-mediated small interfering RNA suppresses
intestinal-type gastric cancer tumorigenicity through the
downregulation of Oct4. Cancer Lett. 32:45–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Asadi MH, Mowla SJ, Fathi F, Aleyasin A,
Asadzadeh J and Atlasi Y: OCT4B1, a novel spliced variant of OCT4,
is highly expressed in gastric cancer and acts as an antiapoptotic
factor. Int J Cancer. 128:2645–2652. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen Z, Xu WR, Qian H, Zhu W, Bu XF, Wang
S, Yan YM, Mao F, Gu HB, Cao HL and Xu XJ: Oct4, a novel marker for
human gastric cancer. J Surg Oncol. 99:414–419. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim RJ and Nam JS: OCT4 expression
enhances features of cancer stem cells in a mouse model of breast
cancer. Lab Anim Res. 27:147–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iida H, Suzuki M, Goitsuka R and Ueno H:
Hypoxia induces CD133 expression in human lung cancer cells by
up-regulation of OCT3/4 and SOX2. Int J Oncol. 40:71–79.
2012.PubMed/NCBI
|
|
10
|
Guo Y, Liu S, Wang P, Zhao S, Wang F, Bing
L, Zhang Y, Ling EA, Gao J and Hao A: Expression profile of
embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human
gliomas. Histopathology. 59:763–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ikushima H, Todo T, Ino Y, Takahashi M,
Saito N, Miyazawa K and Miyazono K: Glioma-initiating cells retain
their tumorigenicity through integration of the Sox axis and Oct4
protein. J Biol Chem. 286:41434–41441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang XF, Zhang WY, Zhao N, Yu W, Ding D,
Hong X, Li LS, Zhang HR, Zheng S and Lin BY: Genome-wide analysis
of OCT4 binding sites in glioblastoma cancer cells. J Zhejiang Univ
Sci B. 12:812–819. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He W, Li K, Wang F, Qin YR and Fan QX:
Expression of OCT4 in human esophageal squamous cell carcinoma is
significantly associated with poorer prognosis. World J
Gastroenterol. 18:712–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saigusa S, Tanaka K, Toiyama Y, Yokoe T,
Okugawa Y, Ioue Y, Miki C and Kusunoki M: Correlation of CD133,
OCT4, and SOX2 in rectal cancer and their association with distant
recurrence after chemoradiotherapy. Ann Surg Oncol. 16:3488–3498.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang CJ, Chien Y, Lu KH, Chang SC, Chou
YC, Huang CS, Chang CH, Chen KH, Chang YL, Tseng LM, Song WS, Wang
JJ, Lin JK, Huang PI and Lan YT: Oct4-related cytokine effects
regulate tumorigenic properties of colorectal cancer cells. Biochem
Biophys Res Commun. 415:245–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gazouli M, Roubelakis MG, Theodoropoulos
GE, Papailiou J, Vaiopoulou A, Pappa KI, Nikiteas N and Anagnou NP:
OCT4 spliced variant OCT4B1 is expressed in human colorectal
cancer. Mol Carcinog. 51:165–173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bates RC and Mercurio AM: The
epithelial-mesenchymal transition (EMT) and colorectal cancer
progression. Cancer Biol Ther. 4:365–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brabletz T, Hlubek F, Spaderna S,
Schmalhofer O, Hiendlmeyer E, Jung A and Kirchner T: Invasion and
metastasis in colorectal cancer: epithelial-mesenchymal transition,
mesenchymal-epithelial transition, stem cells and beta-catenin.
Cells Tissues Organs. 179:56–65. 2005. View Article : Google Scholar
|
|
20
|
Floor S, van Staveren WC, Larsimont D,
Dumont JE and Maenhaut C: Cancer cells in epithelial-to-mesenchymal
transition and tumor-propagating-cancer stem cells: distinct,
overlapping or same populations. Oncogene. 30:4609–4621. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim JB, Greber B, Arauzo-Bravo MJ, Meyer
J, Park KI, Zaehres H and Scholer HR: Direct reprogramming of human
neural stem cells by OCT4. Nature. 461:649–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim JB, Sebastiano V, Wu G, Arauzo-Bravo
MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, et
al: Oct4-induced pluripotency in adult neural stem cells. Cell.
136:411–419. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Monk M and Holding C: Human embryonic
genes re-expressed in cancer cells. Oncogene. 20:8085–8091. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gottardi CJ and Gumbiner BM: Adhesion
signaling: how beta-catenin interacts with its partners. Curr Biol.
11:R792–R794. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim K, Lu Z and Hay ED: Direct evidence
for a role of beta-catenin/LEF-1 signaling pathway in induction of
EMT. Cell Biol Int. 26:463–476. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kolligs FT, Bommer G and Goke B:
Wnt/beta-catenin/tcf signaling: a critical pathway in
gastrointestinal tumorigenesis. Digestion. 66:131–144. 2002.
View Article : Google Scholar : PubMed/NCBI
|
